4.7 Article

Risk assessment of PFASs in drinking water using a probabilistic risk quotient methodology

期刊

SCIENCE OF THE TOTAL ENVIRONMENT
卷 712, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.scitotenv.2019.136485

关键词

PFASs; Drinking water; Occurrence; Human risk assessment; Legislation; Lognormal distribution

向作者/读者索取更多资源

We evaluated health risks associated with perfluorinated and polyfluorinated alkyl substances (PFASs) found in drinking water applying human risk assessment (HRA) methodology. Using data on worldwide occurrence of PFASs in drinking water and recent guidelines for PFASs in drinking water, we applied four scenarios based on different toxicological threshold values to calculate age-dependent risk quotients (RQ) for different PFASs. The mean concentrations of the most frequently detected compounds (PFOS and PFOA) were highest in North America (99.2 and 30.7 ng L-1 respectively), and lowest in Asia (PFOS: 3.0 ng L-1) and Europe (PFOA: 4.87 ng L-1). Using HRA methodology and maximum reported concentrations, only PFOS and PFOA, examined individually, showed any threat to human health. Specifically, calculations with the average and maximum concentrations of PFOS showed RQ values higher than 0.2 or 1, respectively, for some age groups under specific scenarios. Similarly, using maximum PFOA concentrations, a RQ equal to 0.2 for infants up to 3 months was calculated under scenario 4. Regional differences on RQ values were observed when PFOS concentrations from Europe, North America and Asia were used. Estimation of the human health risk due to mixtures of PFASs using average concentrations showed that the RQ(mix) was higher than 0.2 for infants up to 3 months (scenario 3) and infants and children up to 6 years old (scenario 4). More importantly, evaluation of the guideline values set by the EU and the Health Advisory Levels issued by the USEPA resulted (under some scenarios) in RQ values higher than 0.2 for PFOS and PFOA for specific age groups, indicating that further discussion is needed for the monitoring and prioritization of these compounds. (C) 2018 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据